Affiliation
Alimentary Pharmabiotic Centre, University College Cork, Ireland. roy.sleator@cit.ieIssue Date
2009MeSH
AnimalsBiotechnology
Humans
Probiotics
Metadata
Show full item recordCitation
Rational design of improved pharmabiotics. 2009, 2009:275287 J. Biomed. Biotechnol.Journal
Journal of biomedicine & biotechnologyDOI
10.1155/2009/275287PubMed ID
19753318Abstract
Herein we review the most recent advances in probiotic research and applications with particular emphasis on the novel concept of patho-biotechnology: the application of pathogen-derived (ex vivo and in vivo) stress survival strategies for the design of more technologically robust and effective probiotic cultures with improved biotechnological and clinical applications.Language
enISSN
1110-7251ae974a485f413a2113503eed53cd6c53
10.1155/2009/275287
Scopus Count
Collections
Related articles
- Engineered pharmabiotics with improved therapeutic potential.
- Authors: Sleator RD, Hill C
- Issue date: 2008 Jul-Aug
- Patho-biotechnology; using bad bugs to make good bugs better.
- Authors: Sleator RD, Hill C
- Issue date: 2007
- 'Bioengineered Bugs' - a patho-biotechnology approach to probiotic research and applications.
- Authors: Sleator RD, Hill C
- Issue date: 2008
- Patho-biotechnology: using bad bugs to do good things.
- Authors: Sleator RD, Hill C
- Issue date: 2006 Apr
- Probiotic and other functional microbes: from markets to mechanisms.
- Authors: Saxelin M, Tynkkynen S, Mattila-Sandholm T, de Vos WM
- Issue date: 2005 Apr